Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
Previous studies indicated that dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) could serve as a useful biomarker for differentiating malignant from benign orbital lymphoproliferative disorders (OLPDs). To investigate the influence of different region of interest (ROI) selection methods on the measurements of DCE-MRI parameters, and their diagnostic ability in discriminating malignant from benign OLPDs. Retrospective study. In all, 46 patients with OLPDs (22 benign and 24 malignant). 3.T DCE-MRI using a 2D turbo fast low angle shot sequence postcontrast. DCE-MRI data were analyzed using three different ROI selection methods, including whole-tumor ROI (ROIWT ), single-slice ROI (ROISS ) and hot-spot ROI (ROIHS ). Quantitative parameters (Ktrans , Kep , Ve ) were calculated based on a modified Tofts model. Analysis of variance test, intraclass correlation coefficient (ICC), Bland-Altman plots, independent t-test, and receiver operating characteristic curve analyses were used for statistical analyses. The time required for outlining ROIWT was significantly longer than ROISS and ROIHS (P < 0.001). The measurements of DCE-MRI-derived parameters based on ROIHS demonstrated lowest ICC, followed by ROISS and ROIWT . Malignant OLPDs showed significantly higher Kep than benign mimics (P < 0.001), while no significant differences were found on Ktrans (ROIWT , P = 0.535; ROISS , P = 0.557; ROIHS , P = 0.400) and Ve (ROIWT , P = 0.071; ROISS , P = 0.079; ROIHS , P = 0.057). Kep -ROIWT showed the highest area under curve for differentiating malignant from benign OLPDs, followed by Kep -ROISS , and Kep-ROIHS ; however, the differences were not significant (ROIWT vs. ROISS , P = 0.407; ROIWT vs. ROIHS , P = 0.363; ROISS vs. ROIHS , P = 0.887). ROI selection methods could have an influence on the measurements of DCE-MRI parameters. Taking measurement time, reproducibility, and diagnostic ability into account, we suggest single-slice ROI to be used for differentiating malignant from benign OLPDs in clinical practice. 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;47:1298-1305.